Search

Your search keyword '"Pierini, S"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Pierini, S" Remove constraint Author: "Pierini, S" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
71 results on '"Pierini, S"'

Search Results

1. Hybrid device for quantum nanophotonics

2. Exploring the pullback attractors of a low-order quasigeostrophic ocean model: The deterministic case

4. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

5. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

8. Hybrid devices for quantum nanophotonics

14. P2815Antiplatelet therapy with cangrelor in patients undergoing surgery after coronary stent implantation: a real-world bridging protocol experience

20. Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study

21. Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry

23. HALF–DOSE THROMBOLYSIS IN HIGH–RISK PULMONARY EMBOLISM

25. VIGOR: Sviluppo geotermico nella regione Sicilia - Studi di fattibilità a Mazara del Vallo e Termini Imerese, Valutazione geotermica con geofisica elitrasportata

27. Modelling the marine circulation of the Campania coastal system (Tyrrhenian Sea) for the year 2016: Analysis of the dynamics

28. Quaternary marine and continental unconformity-bounded stratigraphic units of the NW Sicily coastal belt

29. Mountain building in NW Sicily from the superimposition of subsequent thrusting and folding events during Neogene: structural setting and tectonic evolution of the Kumeta and Pizzuta ridges

30. Geology of the Kumeta-Pizzuta ridges (NW Sicily)

31. Low-Density Lipoprotein Cholesterol Goal Achievement and Self-Reported Medication Adherence: Insights from the JET-LDL Registry.

32. Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.

33. Atrial fibrillation and ischemic heart disease: (un)solved therapeutic dilemma?

34. Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance.

35. Numerical investigation of the three-dimensional paths of plastic polymers in the Gulf of Naples.

36. Lithium-Ion Glass Gating of HgTe Nanocrystal Film with Designed Light-Matter Coupling.

37. The deterministic excitation paradigm and the late Pleistocene glacial terminations.

38. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.

39. Vanishing Confinement Regime in Terahertz HgTe Nanocrystals Studied under Extreme Conditions of Temperature and Pressure.

41. Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry.

42. Laboratory experiments reveal intrinsic self-sustained oscillations in ocean relevant rotating fluid flows.

43. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty.

44. Tipping points induced by parameter drift in an excitable ocean model.

45. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.

46. Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience.

47. Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial.

48. Timing of Oral P2Y 12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

49. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.

50. [Coagulopathy in COVID-19: pathophysiology].

Catalog

Books, media, physical & digital resources